期刊文献+

无金属脱氧反应合成抗白血病药物克拉屈滨

Efficient Synthesis of Cladribine via Metal-free Deoxygenation
下载PDF
导出
摘要 报道了无金属催化脱氧反应合成标题化合物的新方法。以2-氯-3',5'-二-O-乙酰基腺苷为原料、乙腈为溶剂,2'-羟基和苯氧基硫代酰氯反应,继而以(Bu4N)2S2O8和HCO2Na为非金属脱氧试剂,代替文献报道的Bu3Sn H/AIBN体系,以DMF为溶剂,80℃反应4 h,以82%收率得到脱氧中间体。脱氧中间体在Na2CO3/CH3OH体系中脱除乙酰基。经3步反应以66.3%总收率得到克拉屈滨。该方法高效、简便,不用柱层析,易于操作,为克拉屈滨的制备提供了有效途径。 The synthesis of anti-leukemia drug Cladribine via the metal-free deoxygenation was developed.In acetonitril,2'-hydroxyl group of 2-chloro-3',5'-di-O-acetyladenosine was esterificated with phenyl thioxochloroformate.The esterificated nucleoside was deoxygenated at 80 ℃ for 4 h using(Bu4N)2S2O8and HCO2 Na instead of Bu3 Sn H/AIBN as deoxygenation system,and cladribine could be obtained in 66.3% total yield after the de-acetylation in Na2CO3/CH3 OH system.The intermediates and product could be purified by simple work-up process and chromatography was avoided,which made this route more attractive for industrial applications.
出处 《化学试剂》 CAS 北大核心 2016年第6期511-514,共4页 Chemical Reagents
基金 国家自然科学基金资助项目(21172059)
关键词 克拉屈滨 无金属催化 脱氧 核苷合成 Cladribine metal-free deoxygenation nucleoside synthesis
  • 相关文献

参考文献14

  • 1KONG L R, SAMUELSON E, ROSEN S T, et al. 2-Chlo- rodeoxyadenosine in cutaneous T-cell lymphoproliferative disorders [ J ]. Leuk. Lymphoma., 1997,26 ( 1/2 ) : 89-97.
  • 2JEHN U, BARTL R, DIETZFELBINGER H, et al. Long- term outcome of hairy cell leukemia treated with 2-chloro- deoxyadenosine[ J ]. Ann. Hematol. , 1999,78 ( 3 ) : 139- 144.
  • 3IKEHARA M,TADA H. Studies of nucleosides and nu- cleotides. XXIV. Purine cyclonucleosides. I. 8,2'-Cyclo- nucleoside derived from 2-chloro-8-mereapto-9-~-D-xylo- furanosyladenine[ J ]. J. Am. Chem. Soc. , 1965,87 ( 3 ) : 606-610.
  • 4JANEBA Z, FRANCOM P, ROBINS M J. Efficient synthe- ses of 2-chloro-2'-deoxyadenosine ( cladribine ) from 2'- deoxyguanosine [ J ]. J. Org. Chem. , 2003,68 ( 3 ) : 989- 992.
  • 5陈莉莉,岑均达.克拉屈滨的合成[J].中国医药工业杂志,2005,36(7):387-389. 被引量:6
  • 6ZHONG Ming-hong, NOWAK I, ROBINS M J. Regiospe- cific and highly stereoselective coupling of 6-( substitu- ted-imidazol-l-yl) purines with 2-deoxy-3, 5-di-O-( p- toluoyl)-r-D-erythro-pentofuranosyl chloride. Sodium-salt glycosylation in binary solvent mixtures:improved synthe- sis of cladribine [ J ]. J. Org. Chem., 2006,71 ( 20 ) : 7 773-7 779.
  • 7PENG Yao. A practical synthesis of 2-chloro-2'-deoxyad- enosine (Cladribine) from 2'-deoxyadenosine [ J ]. J. Chem. Res. ,2013,37(4) :213-215.
  • 8XIA Ran, XIE Ming-sheng, NIU Hong-ying, et al. Effi- cient synthesis of nebularine and vidarabine via dehydraz- ination of (hetero)aromatics catalyzed by CuSQ in water [J]. Green Chem. ,2014,16(3) .1 077-1 081.
  • 9XIA Ran, NIU Hong-ying, QU Gui-rong, et al. CuI con- trolled C--C and C--N bond formation of heteroaromatics through C ( sp3 ) -H activation [ J ]. Org. Lett. , 2012,14 (21) :5 546-5 549.
  • 10XIA Ran,XIE Ming-sheng, NIU Hong-ying, et al. Radi- cal route for the alkylation of purine nucleosides at C6 via minisci reaction [ J ]. Org. Lett., 2014,16 ( 2 ) : 444- 447.

二级参考文献7

  • 1Ikehara M, Tada H. A new type of "cyclonucleoside" derived from 2-chloro-8-mercapto-9-β-D-xylofuranosyladenine [J].J Am Chem Soc, 1963, 85 (15): 2344-2345.
  • 2Ikehara M, Tada H. Studies of nucleosides and nucleotides.ⅩⅩⅣ. Purine cyclonucleosides. I. 8,2'-cyclonucleoside derived from 2-chloro-8-mercapto-9-β-D-xylofuranosyladenine [J].JAm Chem Soc, 1965, 87 (3): 606-610.
  • 3Christensen LF, Broom AD. Synthesis and biological activity of selected 2,6-disubstituted- (2-deoxy-α- and -β-D-erythropentofuranosyl) purines [J]. J Med Chem, 1972, 15 (7): 735-739.
  • 4Kazimierczuk Z, Cottam HB, Revankar GR, et al. Synthesis of 2'-deoxytubercidin, 2'-deoxyadenosine, and related 2'-deoxynucleosides via a novel direct stereospecific sodium salt glycosylation procedure [J]. J Am Chem Soc, 1984, 106(21): 6379-6382.
  • 5Gerszberg S, Alonso D. Method for the production of 2-chloro-2'-deoxyadenosine (cladribine) and its 3,5-di-O-p-toluoyl-derivative[P]. US: 2002052491, 2002-05-02.
  • 6Rolland V, Kotera M, Lhomme J. Convenient preparation of 2-deoxy-3,5-di-O-p-toluoyl-α-D-erythro-pentofuranosyl chloride[J]. Synth Commun, 1997, 27 (20): 3505-3511.
  • 7柯乾坤,李科,吴飞.核苷类药物治疗白血病的作用机理与临床应用[J].解放军药学学报,2003,19(2):132-135. 被引量:2

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部